Latest Shareholder Approval News

Chariot Resources has raised $2.15 million in a well-supported placement to fund its acquisition and exploration of lithium assets in Nigeria, signalling strong investor confidence amid soaring lithium prices.

Cann Group Limited has raised $750,000 through a convertible note agreement with Obsidian Global, aiming to strengthen its working capital and move towards EBITDA positivity.

Ore Resources Ltd has acquired four new prospecting licenses adjacent to its Coolgardie Gold and Lithium Project, expanding its landholding to over 80 square kilometres. The company plans systematic exploration targeting promising historical gold intercepts, with drilling set for early Q3 2026.

FAR Limited has agreed on a provisional US$23.7 million contingent payment from Woodside Energy tied to the Sangomar Project, prompting a proposed capital return of A$32.3 million to shareholders.

Oneview Healthcare has successfully raised A$19 million through a two-tranche placement and launched a Security Purchase Plan to further strengthen its financial position and accelerate AI development.

Diversified United Investment Limited (DUI) has registered its Scheme Booklet with ASIC, proposing a merger with Australian United Investment Company Limited (AUI). The Independent Expert concludes the merger is in the best interests of DUI shareholders, with directors unanimously recommending a vote in favour.

iCandy Interactive is exploring a US listing for its subsidiary Lemon Sky Studios to unlock shareholder value, while facing a likely ASX delisting due to audit delays. The company also plans a capital raise to support these initiatives.

Findi Limited has extended the closing date of its offer to 19 March 2026 and updated details following a $25 million institutional placement. The company’s share capital structure and financial position have been revised, with key changes including director participation and lead manager incentives.

Excite Technology Services has secured $1.05 million through convertible notes, aiming to capitalise on its strongest operational cash flow quarter and accelerate growth.

EVE Health Group has raised $0.9 million to advance its pharmaceutical reformulation programs targeting global markets worth over US$30 billion. The funding will support development of improved delivery technologies for medicines nearing patent expiry.

ADX Energy has secured A$4.4 million through a well-supported placement to fund key exploration projects in Austria and Italy, alongside plans for a strategic dual listing on Oslo Børs’ Euronext Growth market.

African Gold Ltd has sent out the Scheme Booklet to shareholders detailing the proposed acquisition by Montage Gold Corp, setting the stage for pivotal meetings on April 13. The Independent Directors back the deal, pending no superior offers and expert endorsement.